Technology NetworksEpigenetic Reprogramming May Significantly Enhance Immunotherapy EfficacyTechnology NetworksIn a paper appearing in the June 29 edition of Cell, researchers led by Ben Youngblood, Ph.D., an assistant member of the St. Jude Department… Continue reading
insider.co.uk |
Ryboquin raises £1.8m to progress development of gene therapy treatment for cancer
insider.co.uk Scottish drug developer Ryboquin has raised a further £1.8m to progress development of its gene therapy treatment for cancer. Backers of the Selkirk-based company include existing investors such as Borders business angel group TRI Capital and the … |
BSA bureau (press release) |
TissueGene awarded $750000 Maryland Stem Cell Grant for Invossa clinical study
BSA bureau (press release) Singapore – TissueGene, Inc., a US-based regenerative medicine company, announced that the Maryland Stem Cell Research Fund (MSCRF) has awarded TissueGene a clinical grant for Invossa, the world’s first cell and gene therapy for degenerative … |
|
Global CRISPR Market: How the Market has witnessed Substantial Growth in recent years and What Factors will drive …
Medgadget (blog) “Global CRISPR Market Size, Status and Forecast 2022”Purchase This Report by calling ResearchnReports.com at +1-888-631-6977. This report presents a 360-degree overview of the competitive scenario of the Global CRISPR market. Thus helping … |
The News (subscription) |
Doctors to offer stem cell treatments
The News (subscription) “World-wide the results with stem cells are off the charts. There are different types of stem cells … blood marrow, which is best used for blood diseases. Amniotic, which is the membrane surrounding the placenta and is the safeguard between the … |